July 7, 2021: Within the Big Ten Cancer Research Consortium, disease-specific Clinical Trial Working Groups are largely focused on developing novel therapeutics to treat and ultimately cure disease. The Big Ten CRC’s Population Science Working Group, led by co-chairs Sharon Manne, PhD, of Rutgers Cancer Institute of New Jersey and Electra Paskett, PhD, of The Ohio State University, has a different goal: To develop and implement population-based research within the Big Ten CRC. “The ultimate goal of our working group is to develop and implement research that reduces the cancer burden in the Big Ten,” said Dr. Manne (pictured left), Chief of Behavioral Sciences and co-Director of the... Read More
July 6, 2021: Big Ten Cancer Research Consortium investigators presented a poster highlighting the BTCRC-AML17-113 study during the American Association for Cancer Research Annual Meeting 2021. Led by John Quigley, MD, of the University of Illinois Cancer Center, the single-arm, open-label, multi-center phase Ib, dose-escalation study examines the safety and efficacy of gemtuzumab ozogamicin and venetoclax in patients with relapsed or refractory CD33+ acute myeloid leukemia. At the time the abstract was presented in April, researchers reported... Read More
June 29, 2021: During the month of July, the Big Ten Cancer Research Consortium highlights the Indiana University Melvin and Bren Simon Comprehensive Cancer Center, and cancer center member Paul Christian Mayor, MD, MS, FACOG. Paul Christian Mayor, MD, MS, FACOG Assistant Professor of Clinical Obstetrics and Gynecology Indiana University School of Medicine Educational Background Medical Degree: Medical College of Georgia, Augusta University Residency: Indiana University School of Medicine Fellowship: Roswell Park Comprehensive Cancer Center Read More
June 27, 2021: In this edition of Across the Consortium, the Big Ten Cancer Research Consortium highlights cancer research ranging from scientists studying links between high cholesterol and breast cancer recurrence to "brain fog" and cognitive dysfunction after chemotherapy. We also share a study on the use of a robotic breast surgery option that may result in improved cosmetic outcomes without compromising cancer control, and how social media is influencing parents’ decisions about whether their children will or will not get the HPV Vaccine. Explore these studies, new appointments, publications, and other general news across the Big Ten CRC. Read More
June 24, 2021: Earlier today, RWJBarnabas Health and Rutgers Cancer Institute of New Jersey, the state’s only National Cancer Institute-designated Comprehensive Cancer Center, in partnership with the New Brunswick Development Corporation, broke ground on the state’s first freestanding cancer hospital. At the ceremony, it was also announced that the 510,000-square-foot structure will be named the Jack and Sheryl Morris Cancer Center in recognition of the philanthropic leadership of Jack Morris, who has been a longtime supporter and pillar in New Brunswick development, and his wife, Sheryl. The 12-story facility, to be located on Somerset Street, will house inpatient, outpatient and ancillary services, as well as state-of-the-art laboratories where research faculty can provide hands-on educational opportunities for... Read More
June 18, 2021: Amanda Parkes, MD, a medical oncologist specializing in sarcoma and breast cancer at the University of Wisconsin Carbone Cancer Center, has been named co-chair of the Big Ten Cancer Research Consortium’s Adolescent and Young Adult (AYA) Clinical Trial Working Group and the Sarcoma Clinical Trial Working Group. Dr. Parkes, an assistant professor at University of Wisconsin School of Medicine and Public Health, has been a member of the consortium’s Breast Cancer Clinical Trial Working Group and the Sarcoma Clinical Trial Working Group since 2018. She has also participated as an investigator in several Big Ten CRC breast cancer trials and is leading the new breast... Read More
June 11, 2021: Big Ten Cancer Research Consortium investigators presented six abstracts during the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting held virtually June 4-8. Read More
June 2, 2021: This month, the Big Ten Cancer Research Consortium highlights our member, Penn State Cancer Institute. Get to know more about Penn State Cancer Institute investigator Monika Joshi, MD, MRCP.
Monika Joshi, MD, MRCP
Associate Professor, Department of Medicine, Division of Hematology and Oncology Penn State Cancer Institute, Next Generation Therapies
Educational Background Medical degree/MBBS: Manipal Academy of Higher Education Residency: UPMC Pinnacle, Harrisburg, Pa. Fellowship: Penn State Health Milton S. Hershey Medical Center, Hershey, Pa. Specialist Registrar (Fellow): University...
Read More
May 23, 2021: In this edition of Across the Consortium, we highlight researchers who are exploring cellular function as it relates to cancer, including drug molecules and genetic mutation, and those who are looking to the physical traits of the mantis shrimp to enhance removal of cancer cells during surgery. We also recognize investigators that are taking on new leadership roles and starting new programs to provide more comprehensive care at their cancer center, and highlight an oncology nurse as part of Nursing Oncology Month. Discover what is happening across the Big Ten CRC. Read More
David Dickens, MD, FAAP, a hematologist-oncologist at the University of Iowa Stead Family Children’s Hospital, is working alongside Amanda Parkes, MD, a medical oncologist specializing in sarcoma and breast cancer at the University of Wisconsin Carbone Cancer Center, to address barriers often faced by this age group as co-chairs of Big Ten CRC’s newly formed Adolescent and Young Adult Clinical Trial Working Group.
Subscribe to the Big Ten CRC Newsletter
X
Facebook
YouTube